- Previous Close
132.82 - Open
127.23 - Bid 128.73 x 900
- Ask 128.94 x 800
- Day's Range
126.02 - 129.97 - 52 Week Range
38.95 - 133.76 - Volume
223,542 - Avg. Volume
638,095 - Market Cap (intraday)
10.732B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
10.80 - EPS (TTM)
11.94 - Earnings Date Apr 21, 2025 - Apr 25, 2025
- Forward Dividend & Yield 1.08 (0.81%)
- Ex-Dividend Date Apr 3, 2025
- 1y Target Est
143.00
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. It offers whole, term, and other life insurance products; and Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products. The company sells its products through its direct-to-consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
www.home.globelifeinsurance.com3,732
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: GL
View More
Performance Overview: GL
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GL
View MoreValuation Measures
Market Cap
11.08B
Enterprise Value
13.65B
Trailing P/E
11.15
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.07
Price/Book (mrq)
2.09
Enterprise Value/Revenue
2.36
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
18.53%
Return on Assets (ttm)
3.23%
Return on Equity (ttm)
21.87%
Revenue (ttm)
5.78B
Net Income Avi to Common (ttm)
1.07B
Diluted EPS (ttm)
11.94
Balance Sheet and Cash Flow
Total Cash (mrq)
250.36M
Total Debt/Equity (mrq)
58.65%
Levered Free Cash Flow (ttm)
1.44B
Research Analysis: GL
View MoreResearch Reports: GL
View MoreRaising target price to $145.00
GLOBE LIFE INC has an Investment Rating of BUY; a target price of $145.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $143.00
GLOBE LIFE INC has an Investment Rating of BUY; a target price of $143.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $139.00
GLOBE LIFE INC has an Investment Rating of BUY; a target price of $139.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $135.00
GLOBE LIFE INC has an Investment Rating of BUY; a target price of $135.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice Target